Though guidelines suggest screening starts at 50, researcher says it's premature to change them
This news article has expired. Below you will find a short description about the news article and comments that were left by CancerCompass users.
Women taking the drug lived more than 3 months longer on average, but side effects were an issue
We care about your feedback. Let us know how we can improve your CancerCompass experience.